ScholarIQanswers from OpenAlex & ORCID
Christopher J. Logothetis
ResearcherPublications, citations & collaboration network
Christopher J. Logothetis is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Christopher J. Logothetis have?
ScholarIQindexed works
Christopher J. Logothetis has 1,147 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Christopher J. Logothetis have?
ScholarIQcitation count
Christopher J. Logothetis has 79,719 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Christopher J. Logothetis?
ScholarIQh-index
Christopher J. Logothetis has an h-index of 120 in OpenAlex.
What is the i10-index of Christopher J. Logothetis?
ScholarIQi10-index
Christopher J. Logothetis has an i10-index of 412 in OpenAlex.
What is the ORCID of Christopher J. Logothetis?
ScholarIQorcid
The ORCID for Christopher J. Logothetis is on the source record.
What is the OpenAlex record for Christopher J. Logothetis?
ScholarIQopenalex
The OpenAlex for Christopher J. Logothetis is on the source record.
What are the most-cited papers on Christopher J. Logothetis?
ScholarIQmost cited works
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. de Bono, Christopher J. Logothetis, Arturo Molina, Karim Fizazi, Scott North, Luis Chu, Kim N., Robert J. Jones, Oscar B. Goodman, Fred Saad, John Staffurth, Paul N. Mainwaring, Stephen Harland, Thomas W. Flaig, Thomas E. Hutson, Tina Cheng, Helen Patterson, John D. Hainsworth, Charles J. Ryan, Cora N. Sternberg, Susan Ellard, Aude Fléchon, Mansoor N. Saleh, Mark C. Scholz, Eleni Efstathiou, Andrea Zivi, Diletta Bianchini, Yohann Loriot, Nicole Chieffo, Thian Kheoh, Christopher M. Haqq, Howard I. Scher
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, Arturo Molina, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Paul N. Mainwaring, Josep M. Piulats, Siobhan Ng, Joan Carles, Peter F.A. Mulders, Ethan Basch, Eric J. Small, Fred Saad, Dirk Schrijvers, Hendrik Van Poppel, Som D. Mukherjee, H. Suttmann, Winald R. Gerritsen, Thomas W. Flaig, Daniel J. George, Evan Y. Yu, Eleni Efstathiou, Allan J. Pantuck, Eric Winquist, Celestia S. Higano, Mary-Ellen Taplin, Youn Park, Thian Kheoh, Thomas W. Griffin, Howard I. Scher, Dana E. Rathkopf
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Howard I. Scher, Michael J. Morris, Walter M. Stadler, Celestia S. Higano, Ethan Basch, Karim Fizazi, Emmanuel S. Antonarakis, Tomasz M. Beer, Michael A. Carducci, Kim N., Paul G. Corn, Johann S. de Bono, Robert Dreicer, Daniel J. George, Elisabeth I. Heath, Maha Hussain, Wm. Kevin Kelly, Glenn Liu, Christopher J. Logothetis, David M. Nanus, Mark N. Stein, Dana E. Rathkopf, Susan F. Slovin, Charles J. Ryan, Oliver Sartor, Eric J. Small, Matthew Raymond Smith, Cora N. Sternberg, Mary-Ellen Taplin, George Wilding, Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong
Steps toward mapping the human vasculature by phage display
Wadih Arap, Mikhail G. Kolonin, Martin Trepel, Johanna Lahdenranta, Marina Cardó‐Vila, Ricardo J. Giordano, Paul J. Mintz, Peter Ardelt, Virginia J. Yao, Claudia I. Vidal, Limor Chen, Anne L. Flamm, Heli Valtanen, Lisa Weavind, Marshall E. Hicks, Raphael E. Pollock, Gregory H. Botz, Corazon D. Bucana, Erkki Koivunen, Dolores J. Cahill, Patricia Troncoso, Keith Baggerly, Rebecca D. Pentz, Kim‐Anh Do, Christopher J. Logothetis, Renata Pasqualini
Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
Ana M. Aparicio, Andrea Harzstark, Paul G. Corn, Sijin Wen, John C. Araujo, Shi‐Ming Tu, Lance C. Pagliaro, Jeri Kim, Randall E. Millikan, Charles J. Ryan, Nizar M. Tannir, Amado J. Zurita, Paul Mathew, Wadih Arap, Patricia Troncoso, Peter F. Thall, Christopher J. Logothetis